 |
PDBsum entry 2g9v
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
The crystal structure of glycogen phosphorylase in complex with (3r, 4r,5r)-5-hydroxymethylpiperidine-3,4-diol and phosphate
|
|
Structure:
|
 |
Glycogen phosphorylase, muscle form. Chain: a. Synonym: myophosphorylase. Ec: 2.4.1.1
|
|
Source:
|
 |
Oryctolagus cuniculus. Rabbit. Organism_taxid: 9986. Tissue: muscle
|
|
Resolution:
|
 |
|
2.15Å
|
R-factor:
|
0.196
|
R-free:
|
0.235
|
|
|
Authors:
|
 |
N.G.Oikonomakos,C.Tiraidis,D.D.Leonidas,S.E.Zographos
|
|
Key ref:
|
 |
N.G.Oikonomakos
et al.
(2006).
Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
J Med Chem,
49,
5687-5701.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Mar-06
|
Release date:
|
16-Jan-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00489
(PYGM_RABIT) -
Glycogen phosphorylase, muscle form from Oryctolagus cuniculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
843 a.a.
807 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.4.1.1
- glycogen phosphorylase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Glycogen
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[(1->4)-alpha-D-glucosyl](n) + phosphate = [(1->4)-alpha-D-glucosyl](n-1) + alpha-D-glucose 1-phosphate
|
 |
 |
 |
 |
 |
[(1->4)-alpha-D-glucosyl](n)
|
+
|
phosphate
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
[(1->4)-alpha-D-glucosyl](n-1)
|
+
|
alpha-D-glucose 1-phosphate
Bound ligand (Het Group name = )
matches with 44.44% similarity
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
49:5687-5701
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
|
|
N.G.Oikonomakos,
C.Tiraidis,
D.D.Leonidas,
S.E.Zographos,
M.Kristiansen,
C.U.Jessen,
L.Nørskov-Lauritsen,
L.Agius.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Iminosugars DAB (5), isofagomine (9), and several N-substituted derivatives have
been identified as potent inhibitors of liver glycogen phosphorylase a (IC(50) =
0.4-1.2 microM) and of basal and glucagon-stimulated glycogenolysis (IC(50) =
1-3 microM). The X-ray structures of 5, 9, and its N-3-phenylpropyl analogue 8
in complex with rabbit muscle glycogen phosphorylase (GPb) shows that
iminosugars bind tightly at the catalytic site in the presence of the substrate
phosphate and induce conformational changes that characterize the R-state
conformation of the enzyme. Charged nitrogen N1 is within hydrogen-bonding
distance with the carbonyl oxygen of His377 (5) and in ionic contact with the
substrate phosphate oxygen (8 and 9). Our findings suggest that the inhibitors
function as oxocarbenium ion transition-state analogues. The conformational
change to the R state provides an explanation for previous findings that 5,
unlike inhibitors that favor the T state, promotes phosphorylation of GPb in
hepatocytes with sequential inactivation of glycogen synthase.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Motoshima,
M.Ishikawa,
K.Sugita,
and
Y.Hashimoto
(2009).
Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists.
|
| |
Biol Pharm Bull,
32,
1618-1620.
|
 |
|
|
|
|
 |
M.Aguilar-Moncayo,
T.M.Gloster,
J.P.Turkenburg,
M.I.García-Moreno,
C.Ortiz Mellet,
G.J.Davies,
and
J.M.García Fernández
(2009).
Glycosidase inhibition by ring-modified castanospermine analogues: tackling enzyme selectivity by inhibitor tailoring.
|
| |
Org Biomol Chem,
7,
2738-2747.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Li,
T.Liu,
Y.Zhang,
S.Favre,
C.Bello,
P.Vogel,
T.D.Butters,
N.G.Oikonomakos,
J.Marrot,
and
Y.Blériot
(2008).
New synthetic seven-membered 1-azasugars displaying potent inhibition towards glycosidases and glucosylceramide transferase.
|
| |
Chembiochem,
9,
253-260.
|
 |
|
|
|
|
 |
K.M.Alexacou,
J.M.Hayes,
C.Tiraidis,
S.E.Zographos,
D.D.Leonidas,
E.D.Chrysina,
G.Archontis,
N.G.Oikonomakos,
J.V.Paul,
B.Varghese,
and
D.Loganathan
(2008).
Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
|
| |
Proteins,
71,
1307-1323.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |